⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 19, 2024Journal of the Endocrine SocietyOpen Access

Nasal Glucagon Reverses Insulin-induced Hypoglycemia With Less Rebound Hyperglycemia: Pooled Analysis of Clinical Trials

Elizabeth R. Seaquist Marga Giménez Yu Yan Munehide Matsuhisa Christi Y. Kao R. Paul Wadwa Yukiko Nagai Kamlesh Khunti

View Full Paper

Ask AI

Bookmark

Share

Abstract

This is the authors' abstract. We don't add key points for this paper.

Rebound hyperglycemia may occur following glucagon treatment for severe hypoglycemia. We assessed rebound hyperglycemia occurrence after nasal glucagon (NG) or injectable glucagon (IG) administration in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Seaquist et al. (2024) studied this question.

synapsesocial.com/papers/68e78968b6db6435876fbd9f https://doi.org/10.1210/jendso/bvae034

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Population pharmacokinetics and pharmacodynamics of nasal glucagon in patients with type 1 or 2 diabetes2024 · 2 citations
2Comparison of glucagon responses to 2-deoxy-D-glucose and hypoglycemia in manother · 1980 · 7 citations
3EXPRESS: Comparing the Efficacy of Transmucosal and Subcutaneous Glucagon Administration in Response to Insulin-Induced Hypoglycemia in Healthy CatsOriginal Research · 2026
41368-P: Glycemic Response to Glucagon in Patients with Post-Bariatric HypoglycemiaClinical Trial · 2026
5Low-Dose Glucagon to Prevent and Treat Exercise-Associated Hypoglycemia in Individuals With Type 1 Diabetes: A Systematic Review and Meta-analysis2025 · 6 citations